Sales 2021
313 B
3 023 M
3 023 M
Net income 2021
71 705 M
692 M
692 M
Net cash position 2021
105 B
1 016 M
1 016 M
P/E ratio 2021
21,7x
Yield 2021
1,57%
Sales 2022
356 B
3 439 M
3 439 M
Net income 2022
86 993 M
839 M
839 M
Net cash position 2022
148 B
1 425 M
1 425 M
P/E ratio 2022
17,7x
Yield 2022
1,90%
Capitalization
1 551 B
14 968 M
14 962 M
EV / Sales 2021
4,61x
EV / Sales 2022
3,94x
Nbr of Employees
3 560
Free-Float
76,6%
ONO PHARMACEUTICAL CO., LTD. is a Japan-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates in one business segment. The Pharmaceutical segment involves in the manufacture and sale of drugs for medical and general use. The Company also involves in the clinical development, introduction and derivation of pharmaceuticals.
Notations Surperformance© of Ono Pharmaceutical Co., Ltd.
Trading Rating :
Investor Rating :
All news about ONO PHARMACEUTICAL CO., LTD.
News in other languages on ONO PHARMACEUTICAL CO., LTD.
Chart ONO PHARMACEUTICAL CO., LTD.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends ONO PHARMACEUTICAL CO., LTD.
Short Term Mid-Term Long Term Trends Bearish Neutral Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
12
Average target price
3 577,27 JPY
Last Close Price
3 107,00 JPY
Spread / Highest target
35,2%
Spread / Average Target
15,1%
Spread / Lowest Target
-6,66%
Please enable JavaScript in your browser's settings to use dynamic charts.